Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. 2invest AG
  6. News
  7. Summary
    2INV   DE000A3H3L44

2INVEST AG

(2INV)
  Report
Real-time Estimate Tradegate  -  05/17 07:30:00 am EDT
11.15 EUR    0.00%
05/13THETA GOLD MINES LIMITED (ASX : TGM) Option to Extend Secure Bond Maturity Date
AQ
04/202invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/23Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from Claris Ventures SGR SpA, 2invest AG
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

4Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020

02/10/2021 | 09:32am EDT
share with twitter
share with LinkedIn
share with facebook

4basebio AG provided earnings Guidance for the full year ended December 31, 2020. For the period, the company expected net profit of EUR 55,075,000 (previous year: net loss of EUR 32,832,000).


© S&P Capital IQ 2021
All news about 2INVEST AG
05/13THETA GOLD MINES LIMITED (ASX : TGM) Option to Extend Secure Bond Maturity Date
AQ
04/202invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/23Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from C..
CI
03/16Kither Biotech s.r.l. announced that it has received €18.5 million in funding from..
CI
02/252INVEST : Preliminary annual results as of 31 December 2021
PU
20212INVEST : Change of forecast for the financial year 2021
PU
2021Revocation of the admission to the Prime Standard
PU
2021Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Ca..
CI
20212Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
20212INVEST : Preliminary half-year results as of 30.06.2021
PU
More news
Financials
Sales 2022 0,36 M 0,37 M 0,37 M
Net income 2022 -4,16 M -4,32 M -4,32 M
Net Debt 2022 6,06 M 6,30 M 6,30 M
P/E ratio 2022 -32,9x
Yield 2022 -
Capitalization 64,1 M 66,7 M 66,7 M
EV / Sales 2022 197x
EV / Sales 2023
Nbr of Employees 3
Free-Float 33,2%
Chart 2INVEST AG
Duration : Period :
2invest AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 2INVEST AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 11,15 €
Average target price 14,25 €
Spread / Average Target 27,8%
EPS Revisions
Managers and Directors
Hansjörg Plaggemars Chief Executive Officer
Alexander Link Chairman-Supervisory Board
Sebastian Paul VP-Finance & Administration
Rainer Herschlein Member-Supervisory Board
Eva Katheder Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
2INVEST AG-14.89%67
INVESTOR AB (PUBL)-20.03%55 456
CK HUTCHISON HOLDINGS LIMITED8.55%26 670
GROUPE BRUXELLES LAMBERT SA-13.67%12 856
HAL TRUST-8.64%12 021
AB INDUSTRIVÄRDEN (PUBL)-13.80%10 624